Author

Barbora Malecova

Sanford Burnham Prebys Medical Discovery Institute - Cited by 1,348 - muscle regeneration - transcription regulation - epigenetics

Biography

Barbora Malecova, belonging to Sanford-Burnham Medical Research Institute, La Jolla, CA, USA. Interested in the field of Quantitative RT-PCR, Immunofluorescence.                               
Title
Cited by
Year
STAT3 signaling controls satellite cell expansion and skeletal muscle repair
MT Tierney, T Aydogdu, D Sala, B Malecova, S Gatto, PL Puri, L Latella, ...Nature medicine 20 (10), 1182-1186, 2014201
362
2014
Signal‐dependent incorporation of MyoD–BAF60c into Brg1‐based SWI/SNF chromatin‐remodelling complex
SV Forcales, S Albini, L Giordani, B Malecova, L Cignolo, A Chernov, ...The EMBO journal 31 (2), 301-316, 2012201
207
2012
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy
B Malecova, S Gatto, U Etxaniz, M Passafaro, A Cortez, C Nicoletti, ...Nature communications 9 (1), 3670, 2018201
132
2018
Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres
S Albini, P Coutinho, B Malecova, L Giordani, A Savchenko, SV Forcales, ...Cell reports 3 (3), 661-670, 2013201
129
2013
Transcriptional gene silencing mediated by non-coding RNAs
B Malecová, KV MorrisCurrent opinion in molecular therapeutics 12 (2), 214, 2010201
121
2010
Nuclear export determines the cytokine sensitivity of STAT transcription factors
I Lödige, A Marg, B Wiesner, B Malecová, T Oelgeschläger, ...Journal of Biological Chemistry 280 (52), 43087-43099, 2005200
72
2005
DEFOG: A practical scheme for deciphering families of genes
T Fuchs, B Malecova, C Linhart, R Sharan, M Khen, R Herwig, ...Genomics 80 (3), 295-302, 2002200
36
2002
The initiator core promoter element antagonizes repression of TATA-directed transcription by negative cofactor NC2
B Malecová, P Gross, M Boyer-Guittaut, S Yavuz, T OelgeschlägerJournal of Biological Chemistry 282 (34), 24767-24776, 2007200
26
2007
TFIIB recognition elements control the TFIIA-NC2 axis in transcriptional regulation
W Deng, B Malecová, T Oelgeschläger, SGE RobertsMolecular and cellular biology 29 (6), 1389-1400, 2009200
24
2009
Myosin phosphatase modulates the cardiac cell fate by regulating the subcellular localization of Nkx2. 5 in a Wnt/Rho–associated protein kinase–dependent pathway
T Ryan, M Shelton, JP Lambert, B Malecova, S Boisvenue, M Ruel, ...Circulation research 112 (2), 257-266, 2013201
21
2013
“Mix of mics”-phenotypic and biological heterogeneity of “multipotent” muscle interstitial cells (MICs)
B Malecova, PL PuriJournal of stem cell research & therapy, 2012201
17
2012
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...US Patent 10,881,743, 2021202
16
2021
Nucleic acid-polypeptide compositions and uses thereof
AJ Geall, VR Doppalapudi, JD Arias, DS Chu, MC Cochran, R Burke, ...US Patent 11,1,180, 2021202
10
2021
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...US Patent 11,253,607, 2022202
8
2022
Single cell gene expression profiling of skeletal muscle-derived cells
S Gatto, PL Puri, B MalecovaMuscle Stem Cells: Methods and Protocols, 191-219, 2017201
8
2017
Taspase1 processing alters TFIIA cofactor properties in the regulation of TFIID
B Malecová, VS Caputo, DF Lee, JJ Hsieh, T OelgeschlägerTranscription 6 (2), 21-32, 2015201
7
2015
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...US Patent App. 17/499,800, 2022202
3
2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...US Patent App. 17/499,796, 0
2
2022
Compositions and methods of treating muscle dystrophy
VR Doppalapudi, MD Hood, R Burke, MC Cochran, BD Darimont, ...US Patent 11,446,387, 0
2
2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AJ Geall, VR Doppalapudi, DS Chu, MC Cochran, M Hood, BD Darimont, ...US Patent 11,497,814, 0
2
2022

Referred From: https://scholar.google.com/citations?user=_wFX3gMAAAAJ&hl=en

Cited by
Citations 1348
h-index 15
i10-index 17
Recommended Journals
Open Access Journals